Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Regulatory & Reimbursement

Rethinking Medtech Pathways in the EU, UK, and New Zealand

In this week’s Pathways Picks: Reform efforts elevate, transition date passes, and cell/tissue bill is adopted in the EU; the UK envisions new medtech market access pathways; New Zealand eyes repeal of health products framework; and more global medtech policy news.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

MedTech Innovator Presents

Opharmic Enables Needle-Free Ocular Drug Delivery

Macromolecules like anti-VEFG are not deliverable as eye drops because they can’t normally penetrate the surface of the eye. But with a novel application of low-frequency ultrasound, Opharmic’s MeticTouch can push drugs to the back-of-the eye, so patients don’t have to undergo the needle.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

ICYMI

Making Early Diagnosis of Inherited Diseases a Clinical Reality

Gene and cell therapies have curative potential for some inherited genetic diseases, but technologies for rapid screening and diagnosis of genetic variants are a prerequisite. An excerpt from our recent interview with Stephen Kingsmore, who is at the forefront of making pediatric genomic testing and newborn screening universal and accessible.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More